Patient and healthcare provider experience of diroximel fumarate: considerations for selecting disease-modifying therapy
{{output}}
Purpose: To evaluate treatment perceptions of diroximel fumarate (DRF) for relapsing multiple sclerosis (MS), with contextual data from dimethyl fumarate (DMF) users, based on patient and healthcare provider (HCP) surveys. ... ...
